M. Agadjanyan

A. Chalian, J. Kim, D. Weiner, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

C. Chen, S. Josephs, A. Ghochikyan, 2011, Journal of Translational Medicine.

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

E. Nelson, A. Ghochikyan, R. Ataullakhanov, 2014, Clinical & Experimental Metastasis.

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

D. Weiner, Y. Refaeli, K. Ugen, 1997, Nature Medicine.

Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

D. Cribbs, G. F. Passos, I. Petrushina, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease

N. Petrovsky, A. Ghochikyan, M. Agadjanyan, 2015, Alzheimer's & Dementia.

Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

V. Vasilevko, D. Cribbs, I. Petrushina, 2008, Journal of Neuroinflammation.

Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.

T. Ichim, W. Min, A. Ghochikyan, 2008, Biochemical and biophysical research communications.

Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.

D. Weiner, V. Srikantan, Y. Refaeli, 2000, DNA and cell biology.

Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses.

V. Srikantan, K. Ugen, J. Boyer, 1995, AIDS.

Refinement of a DNA based Alzheimer disease epitope vaccine in rabbits

A. Kiyatkin, D. Cribbs, I. Petrushina, 2013, Human vaccines & immunotherapeutics.

DNA prime–protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice

D. Cribbs, I. Petrushina, A. Ghochikyan, 2010, Gene Therapy.

Inflammatory changes parallel the early stages of Alzheimer disease

C. Cotman, J. Rogers, V. Perreau, 2007, Neurobiology of Aging.

Anticancer Mechanisms in Two Murine Bone Marrow–Derived Dendritic Cell Subsets Activated with TLR4 Agonists

E. Nelson, A. Ghochikyan, R. Ataullakhanov, 2018, The Journal of Immunology.

Prototype Alzheimer’s Disease Vaccine Using the Immunodominant B Cell Epitope from β-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide1

V. Vasilevko, D. Cribbs, I. Petrushina, 2005, The Journal of Immunology.

Generation and characterization of the humoral immune response to DNA immunization with a chimeric β‐amyloid‐interleukin‐4 minigene

E. Head, V. Vasilevko, D. Cribbs, 2003, European journal of immunology.

An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV.

J. Kim, D. Weiner, S. Kudchodkar, 1997, AIDS research and human retroviruses.

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

N. Petrovsky, D. Cribbs, I. Petrushina, 2019, Alzheimer's Research & Therapy.

Anti-Aβ1–11 Antibody Binds to Different β-Amyloid Species, Inhibits Fibril Formation, and Disaggregates Preformed Fibrils but Not the Most Toxic Oligomers*

A. Kiyatkin, C. Glabe, D. Cribbs, 2007, Journal of Biological Chemistry.

Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

N. Petrovsky, D. Cribbs, I. Petrushina, 2016, Scientific Reports.

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

N. Petrovsky, D. Cribbs, D. Morgan, 2020, Neurobiology of Disease.

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

A. Obenaus, D. Cribbs, I. Petrushina, 2020, Neurobiology of Disease.

Epitope-based DNA vaccine for Alzheimer's disease: Translational study in macaques

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Human vaccines & immunotherapeutics.

DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotype

D. Cribbs, T. Ross, I. Petrushina, 2008, Journal of Neuroimmunology.

Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugates.

V. Vasilevko, D. Cribbs, I. Petrushina, 2006, DNA and cell biology.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Vaccine.

Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial

A. Kiyatkin, L. Pedersen, D. Cribbs, 2013, The Journal of Neuroscience.

The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

R. Albrecht, A. García-Sastre, I. Petrushina, 2011, Journal of Translational Medicine.

Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble/Oligomeric Aβ Species in Amyloid Precursor Protein Transgenic Mice

E. Head, D. Cribbs, I. Petrushina, 2007, The Journal of Neuroscience.

DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1.

D. Weiner, K. Ugen, S. Nyland, 1998, Current topics in microbiology and immunology.

Immunization with fibrillar Aβ1–42 in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Aβ

C. Cotman, M. Murphy, N. Milgram, 2006 .

Pan HLA DR-Binding Peptide -Amyloid and Promiscuous T Cell Epitope b the Immunodominant B Cell Epitope from Prototype Alzheimer's Disease Vaccine Using

V. Vasilevko, D. Cribbs, I. Petrushina, 2005 .

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines

L. Pedersen, D. Cribbs, I. Petrushina, 2014, Journal of Neuroimmunology.

Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.

E. Head, D. Cribbs, I. Petrushina, 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers.

A. Kiyatkin, C. Glabe, D. Cribbs, 2007, The Journal of biological chemistry.

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

D. Cribbs, I. Petrushina, M. Blurton-Jones, 2023, International journal of molecular sciences.

A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors

D. Loukinov, A. Anderson, Victor Lobanenkov, 2023, International journal of molecular sciences.

Antigen‐specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN‐γ, IL‐12, or IL‐18 gene adjuvants

D. Weiner, K. Ugen, H. Maguire, 1999, Journal of medical primatology.

Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.

D. Weiner, K. Ugen, G. Gevorkian, 2000, Virology.

Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.

D. Weiner, V. Srikantan, M. Kaplan, 1993, AIDS research and human retroviruses.

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Molecular Neurodegeneration.

Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

V. Vasilevko, D. Cribbs, I. Petrushina, 2008, Journal of Neuroinflammation.

Aβ-Immunotherapy for Alzheimer's Disease Using Mannan–Amyloid-Beta Peptide Immunoconjugates

V. Vasilevko, D. Cribbs, I. Petrushina, 2006 .

A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss

P. Rakic, V. Kepe, J. Barrio, 2013, The Journal of Neuroscience.

MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.

D. Cribbs, I. Petrushina, Joy L. Davis, 2017, Vaccine.

The MultiTEP platform–based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates

D. Cribbs, I. Petrushina, A. Ghochikyan, 2014, Alzheimer's & Dementia.

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

E. Nelson, A. Ghochikyan, R. Ataullakhanov, 2013, Clinical & Experimental Metastasis.